The company's high P/S ratio and decreasing revenues do not ...

Moomoo AI Dec 18, 2023 09:33

The company's high P/S ratio and decreasing revenues do not match, causing concerns for investors. Unless the recent medium-term conditions improve significantly, investors may find it difficult to perceive the share price as fair value.

Hybio Pharmaceutical Co., Ltd.'s (SZSE:300199) Popularity With Investors Is Under Threat From Overpricing

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

4900 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4953

Followers

Following

11K

Visitors